Health
Pfizer’s anti-viral 3CL protease inhibitor shows antiviral potential against SARS-CoV-2 – News-Medical.Net
Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv in September 2020 reports that an enzyme inhibitor may act …
The COVID-19 pandemic has still not been countered by effective drugs or antivirals, which is the reason for the continued restrictions on mobility and social interactions in most countries the world over. Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv* in September 2020 reports that an enzyme inhibitor may act in synergism with the approved ant…
-
Noosa News14 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
General13 hours agoAustralia welcomes Gaza peace progress, hostage release
-
Business16 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News20 hours ago28 years later: Grim reality for single house hunters revealed